Japan's approval of the world’s first medical treatments using reprogrammed human cells signals a new era in regenerative medicine, offering hope for patients with heart failure and Parkinson’s ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.

Cardiac reprogramming is a technique to directly convert nonmyocytes into myocardial cells using genes or small molecules. This intervention provides functional benefit to the rodent heart when ...